Mary Lyon Centre at MRC Harwell
@MRCHarwell
The UK’s national facility for mouse genetics and the use of mouse models for the pre-clinical study of human disease.
ID:1685620472
http://www.har.mrc.ac.uk 20-08-2013 11:57:15
3,1K Tweets
2,2K Followers
1,8K Following
Day 2 of #DMMgenetics brings more incredible talks and more Network’s involvement with Microbiome Cluster, MRC NMGN Cancer Cluster, MRC MitoCluster and MRC NMGN Haem Cluster. Royal Society of Edinburgh The Company of Biologists
The Network and Mary Lyon Centre at MRC Harwell taking centre stage with MRC NMGN Cancer Cluster, MRC NMGN Haem Cluster, MRC NMGN Congenital Anomalies and MRC MitoCluster representatives either chairing or speaking at today’s #DMMgenetics sessions.
This one was an Understanding Animal Research Openness Award recipient in 2020 and the beginning of a huge body of work still ongoing, partly with COST_TEATIME and many other collaborators! #BOARD24 har.mrc.ac.uk/news/citizen-s…
📢 #BOARD24 is happening this Friday 3 May!
🌍 Our global, 24-hr social media campaign will be taking place during the Understanding Animal Research #Openness24 conference, where EARA will be presenting several sessions on transparency in #AnimalResearch !
🚨 Don't miss it!
Registration is now open for the 2nd workshop in the IMPC Workshop series 2024, titled ‘IMPC Data API Workshop’ and is taking place online on Monday, the 20th May 2024. To register and more: mousephenotype.org/blog/2024/04/1…
We look forward to welcoming you to this event!
#IMPCWorkshops24
📢Check out the upcoming event on 'Resources and Funding Opportunities in Rare Disease', which will be held on June 6th at the Advance Training Centre Mary Lyon Centre at MRC Harwell.
Follow the link to register! docs.google.com/forms/d/e/1FAI…
Most in vivo studies use male animals but using both sexes should be the default to avoid wastage of females and prevent sex-bias in research. The Sex Inclusive Research Framework (SIRF) helps you to check if sex has been fully considered in study design: openinnovation.astrazeneca.com/preclinical-re…